Similar medications and substitutes for TREMELIMUMAB
In short: Imjudo (TREMELIMUMAB) belongs to the CTLA-4-directed Blocking Antibody class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Imjudo is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Imjudo in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.